









Markets
/
Stocks
/
nasdaq-pfe
/

Pfizer Inc

PFE

View Detailed Chart

25.045USD

+0.805+3.32%

Close 07/01, 16:00（ET）Quotes delayed by 15 min

142.38BMarket Cap

18.06P/E TTM



Pfizer Inc

25.045

+0.805+3.32%

Company

Intraday

30m

Today

+3.32%

5 Days

+3.02%

1 Month

+6.62%

6 Months

-5.60%

Year to Date

-5.60%

1 Year

-11.25%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 25 analysts

HOLD

Current Rating

28.571

Target Price

17.87%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

168

Total

Median

Average

Company name

Ratings

Analysts

Pfizer Inc

PFE

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Pfizer Inc Trading Strategy

Short Term

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(4)

Neutral(3)

Buy(6)

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.024

Neutral

RSI(14)

56.180

Neutral

STOCH(KDJ)(9,3,3)

58.675

Buy

ATR(14)

0.359

Low Volatility

CCI(14)

-6.309

Neutral

Williams %R

59.916

Sell

TRIX(12,20)

0.174

Sell

StochRSI(14)

36.734

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

24.248

Buy

MA10

24.152

Buy

MA20

24.016

Buy

MA50

23.447

Buy

MA100

24.320

Buy

MA200

25.817

Sell

News

Trump executive order demands pharma industry price cuts

WASHINGTON, May 12 (Reuters) - U.S. President Donald Trump signed a wide-reaching executive order on Monday directing drugmakers to lower the prices of their medicines to align with what other countries pay that analysts and legal experts said would be difficult to implement.

ReutersTue, May 13

Trump Plans Major Drug Price Cuts, Pharma Stocks Tumbles

Trump signals an executive order to slash drug prices, causing a sharp sell-off in Asian pharmaceutical stocks. Major companies like Johnson & Johnson, Pfizer, and Abbott could be hit hard.

TradingKeyMon, May 12

The Strategic Repositioning Driving Pfizer's Growth Story

TradingKey - Pfizer’s non-COVID portfolio grew 12% in 2024, led by a 65% surge in Vyndaqel sales and 26% oncology revenue growth.

TradingKeyTue, Apr 8

Pfizer sells entire Haleon stake for $3.24 billion

March 19 (Reuters) - Drugmaker Pfizer PFE.N has sold its entire stake in Haleon HLN.L for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for the deal said on Wednesday.

ReutersWed, Mar 19

Company

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment includes the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its oncology products include Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak and Talzenna. Its primary care products include Eliquis, Nurtec ODT/Vydura, Zavzpret, the Prevnar family, Comirnaty, Abrysvo, FSME/IMMUN-TicoVac, Nimenrix, Trumenba, and Paxlovid. Its specialty care products include Xeljanz, Enbrel (outside the United States and Canada), Inflectra, Abrilada, Cibinqo, Litfulo, Eucrisa, Velsipity, the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, Hympavzi, Sulperazon, Zavicefta, Octagam and others.

Ticker SymbolPFE

CompanyPfizer Inc

CEODr. Albert Bourla, Ph.D.

Websitehttps://www.pfizer.com/